MPM Capital
Boston, Massachusetts
MPM BioImpact is a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in companies that seek to translate scientific innovations into cures for major diseases. With its world-class team and deep experience in scientific research, clinical development, and company-building, MPM BioImpact strives to power novel medical breakthroughs that transform patients’ lives. MPM BioImpact invests across the biotech landscape from early stage start-ups to public companies.
Founded:1996
Firm Location:Boston, Massachusetts • Atherton
Investor Firms That Co-Invest with MPM Capital
Norwest Venture PartnersAtlas VentureBessemer Venture PartnersPfizer Venture InvestmentsDigitalis VenturesRA Capital ManagementARCH Venture PartnersTPG BiotechAbingworthOrbiMedLongwood Fund6 Dimensions CapitalRed Tree Venture CapitalPureos BioventuresMPM BioImpactVida Ventures, LLCOsage University Partners (OUP)Scleroderma Research FoundationS.R. One LtdBarron Park AssociationAescapAstellas Pharma US
MPM Capital Team
Investors in Boston (MA), Investors in Cambridge (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in BioTech (Pre-seed)
Investors in SF Bay Area (CA), Investors in Atherton
Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in San Francisco Bay Area (Other Lists), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B)
Investors in Munich (Germany)